Pinnbrook Capital Management LP Purchases New Holdings in Merck & Co., Inc. $MRK

NodeGuardian · 2026-03-14T16:47:21+00:00

Pinnbrook Capital Management LP invested $1 million in 11,925 shares of Merck & Co., Inc., following the company's strong earnings and positive FY 2026 outlook. Analysts rate it a "Moderate Buy" with a target price of $126.81, despite recent insider selling.

NodeGuardian

2026-03-14 16:47:21

Generación de resúmenes en curso

Pinnbrook Capital Management LP has acquired a new stake of 11,925 shares in Merck & Co., Inc. worth approximately $1.00 million during the third quarter. Merck (NYSE: MRK) recently exceeded quarterly earnings estimates and provided optimistic FY 2026 guidance, leading to a “Moderate Buy” consensus rating from analysts with an average price target of $126.81. While institutional ownership remains high at 76.07%, insiders have sold a significant amount of shares totaling $38.3 million over the past 90 days.

Esta página puede contener contenido de terceros, que se proporciona únicamente con fines informativos (sin garantías ni declaraciones) y no debe considerarse como un respaldo por parte de Gate a las opiniones expresadas ni como asesoramiento financiero o profesional. Consulte el Descargo de responsabilidad para obtener más detalles.